BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  GSK Inks Potential $1.4 Billion Oncology Deal With Belgium-Based iTeos

  Shares of iTeos Therapeutics skyrocketed more than 50% in premarket trading after it struck an agreement with GSM to co-develop and commercialize a cancer treatment.

  June 14, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  BioMidwest

  Study Identifies Mechanisms Underlying Cognitive Impairment in COVID-19 Long-Haulers

  Investigators from the Cleveland Clinic assessed possible relationships between COVID-19 and neuroinflammation and brain microvascular injury – two hallmarks of AD.

  June 14, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Drug Development

  FDA Once Again Rejects Avenue Therapeutics’ NDA for IV Non-Opioid Painkiller Tramadol

  Avenue Therpeutics is facing the heat of rejection from FDA once again for its IV non-opioid painkiller tramadol. Here are the reasons behind the rejections

  June 14, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Business

  CRISPR and Capsida Partner in Gene Edited Therapies for ALS, Friedreich’s Ataxia

  Per the agreement, CRISPR will lead the research and development of the Friedreich’s ataxia program, while Capsida will shepherd the R&D for the ALS effort.

  June 14, 2021

   · 

  3 min read

   · 

  Heather McKenzie
• 

  Deals

  Brooklyn ImmunoTherapeutics Plans Acquisition to Advance Next-Gen Gene and Cell Therapy Programs

  Brooklyn ImmunoTherapeutics and Novellus have been doing quite a bit of business together lately, including a licensing agreement and co-locating at a research and development center. Now, a potential acquisition can be added to the growing list.

  June 14, 2021

   · 

  2 min read

   · 

  Ellen Bombela
• 

  Genetown

  Flagship Pioneering Takes Aim at Global Health Threats with $3.37 Billion Fund

  Flagship Pioneering announced a massive cash infusion to support the development and launch of new companies aiming at various diseases and global health threats.

  June 14, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Novavax’s COVID-19 Vaccine is 90.4% Effective, According to New Study Findings

  The study also found the vaccine was 100% effective at preventing moderate and severe disease.

  June 14, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Drug Development

  Janssen Hits Two Phase III Marks in Hematology Presentations at EHA

  Janssen presented the Phase III Glow study for the elderly with CLL or SLL and the overall survival results from the Phase III MAIA study for patients with NDMM.

  June 14, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  EU Hits AstraZeneca Vaccine with Another Blood Condition for Side Effect List

  The EMA identified a rare blood condition, capillary leak syndrome, as a potential side effect of AstraZeneca’s Vaxzevria.

  June 14, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Drug Development

  Enochian BioSciences Aims to Advance HIV Treatment That Could Provide Functional Cure

  The FDA accepted its pre-Investigational New Drug request for a cell therapy treatment that could be a key factor in controlling HIV.

  June 14, 2021

   · 

  2 min read

   · 

  Alex Keown